Skip to Main Content

Dr. Simone Difilippantonio: Bibliography

Dr. Simone Difilippantonio - Speaker Bibliography

Bibliographies

Included is a selective bibliography of works for a speaker presenting at the National Cancer Institute at Frederick (NCI-Frederick). Bibliographies are created and maintained by the Scientific Library staff searching standard bibliographic databases such as PubMed and Web of Science.

Selective Bibliography of Dr. Simone Difilippantonio
Laboratory Animal Sciences Directorate, NCI

"Technology Development"
Tuesday, June 15, 2021

1.  Shrestha RL, Rossi A, Wangsa D, Hogan AK, Zaldana KS, Suva E, Chung YJ, Sanders CL, Difilippantonio S, Karpova TS, Karim B, Foltz DR, Fachinetti D, Aplan PD, Ried T, Basrai MA
CENP-A overexpression promotes aneuploidy with karyotypic heterogeneity
Journal of Cell Biology 220 (4):Apr 5 2021

2.  Valencia SM, Zacharia A, Marin A, Matthews RL, Wu CK, Myers B, Sanders C, Difilippantonio S, Kirnbauer R, Roden RB, Pinto LA, Shoemaker RH, Andrianov AK, Marshall JD
Improvement of RG1-VLP vaccine performance in BALB/c mice by substitution of alhydrogel with the next generation polyphosphazene adjuvant PCEP
Human Vaccines & Immunotherapeutics 1-14 Feb 11 2021

3.  Torres-Ayuso P, An E, Nyswaner KM, Bensen RC, Ritt DA, Specht SI, Das S, Andresson T, Cachau RE, Liang RJ, Ries AL, Robinson CM, Difilippantonio S, Gouker B, Bassel L, Karim BO, Miller CJ, Turk BE, Morrison DK, Brognard J
TNIK is a therapeutic target in Lung Squamous Cell Carcinoma and regulates FAK activation through Merlin
Cancer Discovery Jan 25 2021

4.  Zacharia A, Harberts E, Valencia SM, Myers B, Sanders C, Jain A, Larson NR, Middaugh CR, Picking WD, Difilippantonio S, Kirnbauer R, Roden RB, Pinto LA, Shoemaker RH, Ernst RK, Marshall JD
Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists
Vaccine 39 (2):292-302 Jan 8 2021

5.  Gril B, Wei D, Zimmer AS, Robinson C, Khan I, Difilippantonio S, Overstreet MG, Steeg PS
HER2 antibody-drug conjugate controls growth of breast cancer brain metastases in hematogenous xenograft models, with heterogeneous blood-tumor barrier penetration unlinked to a passive marker
Neuro Oncology 22 (11):1625-1636 Nov 26 2020

6.  Marzi L, Sun Y, Huang SN, James A, Difilippantonio S, Pommier Y
The Indenoisoquinoline LMP517: A Novel Antitumor Agent Targeting both TOP1 and TOP2
Molecular Cancer Therapeutics 19 (8):1589-1597 Aug 2020

7.  Luciano MP, Crooke SN, Nourian S, Dingle I, Nani RR, Kline G, Patel NL, Robinson CM, Difilippantonio S, Kalen JD, Finn MG, Schnermann MJ
A Nonaggregating Heptamethine Cyanine for Building Brighter Labeled Biomolecules
ACS Chemical Biology 14 (5):934-940 May 17 2019

8.  Marzi L, Agama K, Murai J, Difilippantonio S, James A, Peer CJ, Figg WD, Beck D, Elsayed MSA, Cushman M, Pommier Y
Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors
Molecular Cancer Therapeutics 17 (8):1694-1704 Aug 2018

9.  Gril B, Paranjape AN, Woditschka S, Hua E, Dolan EL, Hanson J, Wu X, Kloc W, Izycka-Swieszewska E, Duchnowska R, Peksa R, Biernat W, Jassem J, Nayyar N, Brastianos PK, Hall OM, Peer CJ, Figg WD, Pauly GT, Robinson C, Difilippantonio S, Bialecki E, Metellus P, Schneider JP, Steeg PS
Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases
Nature Communications 9 (1):2705 Jul 13 2018

10.  Yohe ME, Gryder BE, Shern JF, Song YK, Chou HC, Sindiri S, Mendoza A, Patidar R, Zhang X, Guha R, Butcher D, Isanogle KA, Robinson CM, Luo X, Chen JQ, Walton A, Awasthi P, Edmondson EF, Difilippantonio S, Wei JS, Zhao K, Ferrer M, Thomas CJ, Khan J
MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma
Science Translational Medicine 10 (448):Jul 4 2018